Medicare Enrolled

Dr. Brad Lipson, D.O.

Family Medicine · Royal Palm Beach, FL
Low-engagement
11903 SOUTHERN BLVD, Royal Palm Beach, FL 33411
5617931475
In practice since 2006 (19 years)
NPI: 1508930447 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lipson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lipson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lipson

Dr. Brad Lipson is a family medicine in Royal Palm Beach, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Lipson received a total of $24,224 from 43 pharmaceutical and/or device companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lipson is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $24,224 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$24,224
Total received (2018-2024)
Avg $3,461/year across 7 years
Top 1% in FL for family medicine
43
Companies
532
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,882 (69.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,944 (28.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$398 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,771
2023
$1,125
2022
$2,338
2021
$3,265
2020
$2,700
2019
$3,004
2018
$9,021

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$6,639
Eli Lilly and Company
$2,771
Novo Nordisk Inc
$2,256
AstraZeneca Pharmaceuticals LP
$1,598
Genentech USA, Inc.
$983
Lilly USA, LLC
$826
AbbVie Inc.
$771
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$715
Amarin Pharma Inc.
$680
Novo Nordisk AS
$680
Boehringer Ingelheim Pharmaceuticals, Inc.
$661
Allergan Inc.
$571
Janssen Pharmaceuticals, Inc
$536
Biohaven Pharmaceuticals, Inc.
$435
PFIZER INC.
$431
Ascensia Diabetes Care US Inc.
$398
Allergan, Inc.
$398
ABBVIE INC.
$398
SANOFI-AVENTIS U.S. LLC
$335
Bausch Health US, LLC
$291
Biohaven Pharmaceutical Holding Company Ltd.
$256
Teva Pharmaceuticals USA, Inc.
$182
Kaneka Pharma America LLC
$155
Merck Sharp & Dohme Corporation
$137
Takeda Pharmaceuticals U.S.A., Inc.
$135
BIOTRONIK INC.
$108
Abbott Laboratories
$90
Orexo US, Inc.
$89
Eisai Inc.
$81
GlaxoSmithKline, LLC.
$78
Bayer HealthCare Pharmaceuticals Inc.
$76
Adlon Therapeutics L.P.
$68
Gilead Sciences, Inc.
$66
Horizon Therapeutics plc
$62
Novartis Pharmaceuticals Corporation
$61
Indivior Inc.
$47
Merck Sharp & Dohme LLC
$44
Biogen, Inc.
$24
MannKind Corporation
$22
Alkermes, Inc.
$22
Currax Pharmaceuticals LLC
$16
Esperion Therapeutics, Inc.
$16
Scilex Pharmaceuticals Inc.
$16
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
ADHANSIA XR · AFREZZA · AJOVY · APLENZIN · Aimovig · BELSOMRA · BREZTRI · BYDUREON · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CYCLOSET · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LUCEMYRA · LYRICA · MOUNJARO · NEXLIZET · NURTEC ODT · Otezla · Ozempic · PREVNAR 13 · QULIPTA · RAYOS · REYVOW · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SPINRAZA · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUBLOCADE · SYMBICORT · SYNTHROID · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Truvada · UBRELVY · VIVITROL · VRAYLAR · VYVANSE · Vascepa · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in FL.

Looking for a family medicine in Royal Palm Beach?
Compare family medicines in the Royal Palm Beach area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
429
Per 100K population
28.5
County median income
$81,115
Nearest hospital
WELLINGTON REGIONAL MEDICAL CENTER
5.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lipson is a family medicine, and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Lipson receive payments from pharmaceutical companies?
Yes. Dr. Lipson received a total of $24,224 from 43 companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lipson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →